A boutique asset management firm with global perspectives and value investment focus
Research-Driven · Long-term Value Creation · Sustainable Growth Strategies
Schedule ConsultationFounded in 2025, HanLing Capital is a professional asset management firm rooted in China with a global perspective. "Han" represents our vast investment vision and profound research capabilities, while "Ling" symbolizes our precise grasp of value and strategic positioning for long-term accumulation.
Our core philosophy is to discover investment opportunities with long-term competitive advantages and intrinsic value globally through in-depth industry research and rigorous investment analysis. Our team brings together elite talents from top investment banks, private equity firms, consulting companies, and industry-leading enterprises, with an average of over 15 years of investment and management experience.
HanLing Capital adheres to the investment philosophy of "value investment, long-termism, and research-driven," dedicated to providing comprehensive asset allocation and value-added services for institutional investors, family offices, and high-net-worth individuals. We have established a strict risk management system and ESG investment standards to ensure that our investment portfolio maintains stability and sustainability while pursuing excess returns.
As a responsible investment institution, we focus not only on financial returns but also on creating long-term value for our portfolio companies, promoting sustainable development of the real economy and society. We believe that only by creating true social value can we obtain lasting investment returns.
Conducting business with the highest ethical standards and principles of integrity, always placing client interests first
Pursuing continuous improvement in professional knowledge and investment capabilities, striving for excellence in every aspect
Adhering to long-term value creation, avoiding short-term speculation, focusing on sustainable growth models
Making rational investment decisions based on in-depth fundamental research and systematic analysis
HanLing Capital has constructed a diversified investment strategy system covering high-quality investment opportunities across different stages and industries. We combine global vision with local insights to create long-term value across market cycles.
Focusing on industry-leading enterprises in their growth and mature stages, driving a new round of value release through deep operational empowerment and strategic upgrades. Our key areas of focus include:
Through a systematic value creation methodology, we assist enterprises in optimizing operational efficiency, expanding market boundaries, enhancing brand value, and realizing value through IPOs or strategic M&A at appropriate times.
Investing in early and growth-stage enterprises with disruptive technologies and innovative business models, cultivating the next generation of industry leaders. Our venture investments focus on:
We provide not only financial support but also build a comprehensive growth accelerator for startups through industry expert networks, strategic resource matching, and talent recruitment, improving success rates and growth speeds.
Creating synergistic value by identifying industry integration opportunities and implementing strategic acquisitions and business restructuring. Our M&A strategies include:
With the team's rich transaction experience and cross-industry operational knowledge, we can accurately identify and realize business integration and value enhancement after acquisitions.
Adopting a research-intensive strategy to discover undervalued quality companies in public markets and achieve excess returns through long-term holdings. Our investment philosophy is based on:
Our portfolio typically includes 20-30 carefully selected stocks with an investment cycle of 3-5 years, committed to providing robust absolute returns in different market environments.
Targeting special investment opportunities arising from market fluctuations and structural changes, including:
We have a professional special situations analysis team capable of quickly assessing risks and opportunities in complex environments, capturing rare asymmetric return opportunities.
Providing alternative asset allocation solutions for investors seeking diversification and inflation protection, including:
Our alternative asset portfolios are designed to provide low volatility, stable cash flow, and inflation hedging characteristics, achieving low correlation with traditional assets.
The following are some of HanLing Capital's representative investment cases, showcasing our professional capabilities and value creation practices across different industries and investment stages.
Private Equity Investment | Manufacturing Upgrade
Investment Overview: Led Series C financing of $300 million in 2025, acquiring 20% equity
Company Profile: A leading domestic industrial robot and intelligent manufacturing system solutions provider with core proprietary intellectual property and industry-leading technology
Value Creation: Assisted the enterprise in optimizing product lines, restructuring sales channels, introducing international management teams, and promoting global market expansion, resulting in 150% revenue growth and an 8 percentage point profit margin improvement within two years
Exit Plan: Planned exit through IPO on the STAR Market
Growth Investment | Consumer Upgrade
Investment Overview: Invested RMB 500 million in 2026, becoming the second-largest shareholder
Company Profile: Integrating multiple emerging domestic brands in niche markets, covering beauty, functional foods, and lifestyle products, with strong social media marketing capabilities and young consumer loyalty
Value Creation: Introduced supply chain optimization systems, established omni-channel operational capabilities, aided in data-driven decision system upgrades, resulting in a 12% increase in gross profit margin and a 30% improvement in user retention rate within one year
Latest Progress: Valuation has tripled since investment, with plans to initiate the IPO process within the next 18 months
Venture Capital | Biotechnology
Investment Overview: Series A investment of RMB 100 million in 2026
Company Profile: Focusing on the application of gene editing technology in rare disease treatment, possessing an independently developed high-precision gene editing platform and multiple PCT international patents
Value Creation: Introduced an international top-tier scientific advisory team, assisted in establishing FDA compliance quality systems, promoted international clinical cooperation projects, and accelerated core product clinical trial processes
Latest Progress: Completed two key technical milestones, received strategic investment from international large pharmaceutical companies, with a fivefold increase in valuation
M&A Restructuring | Logistics Technology
Investment Overview: Completed the acquisition and integration of two regional logistics enterprises in 2025, with a total investment of RMB 1.2 billion
Company Profile: Utilizing artificial intelligence and blockchain technology to empower traditional logistics services, providing end-to-end global supply chain solutions
Value Creation: Integrated regional quality resources, unified technology platforms and service standards, implemented digital transformation, and established a global network, expanding service coverage to 35 countries within two years with a 200% revenue growth
Exit Planning: Planning to introduce strategic investors through M&A or list on the Hong Kong Stock Exchange
HanLing Capital's investment decisions are built on a foundation of in-depth research. We regularly publish industry research reports and market insights, sharing our unique perspectives on investment trends and opportunities.
June 2026
This report deeply analyzes the key driving factors and development paths of China's manufacturing digital transformation, exploring the strategic positioning and opportunities and challenges for Chinese enterprises in the context of global supply chain restructuring.
Download Report SummaryApril 2026
The report focuses on cutting-edge technological breakthroughs in the biomedical field, including gene editing, precision medicine, and AI-assisted drug discovery, analyzing the commercialization pathways and investment strategies from laboratory to market.
Download Report SummaryMarch 2026
Based on in-depth research of 10,000 Generation Z consumers in five major Asian markets, revealing the values, consumption habits, and brand preferences of the new generation of consumers, providing decision-making references for consumer brand investments.
Download Report SummaryJanuary 2026
The report analyzes investment opportunities under global energy transition trends, covering clean energy, energy storage technology, smart grids, and carbon neutrality solutions, providing a systematic risk-return assessment framework.
Download Report SummaryDecember 2025
In-depth analysis of the development prospects of emerging fintech fields such as digital payments, decentralized finance, digital assets, and regulatory technology, evaluating the impact of regulatory environment changes on industry patterns.
Download Report SummaryOctober 2025
Comprehensively combing through application scenarios and commercial value of artificial intelligence technology in various industries, analyzing investment hotspots and return potential of the AI industry value chain, providing differentiated investment strategy recommendations.
Download Report SummaryRegularly receive HanLing Capital's latest research reports, market insights, and investment thoughts
HanLing Capital brings together industry elites to build a professional investment team with both global vision and local insights. Team members have an average of over 15 years of investment and management experience, having served at top global financial institutions and consulting firms.
Founding Partner & CEO
With 20 years of investment banking and private equity investment experience, he previously served as Managing Director of Goldman Sachs Asia Pacific M&A department, leading the completion of M&A and financing projects totaling over $50 billion. MBA from Harvard Business School, Bachelor of Finance from Peking University.
Mr. Zhang focuses on technology and consumer sector investments, having led investments in multiple unicorn companies with successful exits. He also serves as a visiting professor at Tsinghua University School of Economics and Management and has authored investment books including "The Art of Value Investing".
Managing Partner & CIO
Former Director of BlackRock's Asian Equity Investment Department, with 18 years of alternative investment experience, focusing on technology, healthcare, and consumer upgrading sectors. MBA from Stanford University, Bachelor of Economics from Cambridge University.
Ms. Li has led growth-stage investments in many industry-leading enterprises and successfully guided multiple portfolio companies to IPO completion. She is known for her in-depth industry research and forward-looking investment vision, having been consecutively named one of Asia's 50 Most Influential Investors for three years.
Partner & Research Director
PhD in Economics from the University of Chicago, former Head of Macro Research at Bridgewater Fund, Chief Economist (Asia Pacific) at UBS Group. Possesses rich experience in macroeconomic and market cycle research.
Dr. Wang has established HanLing Capital's unique research framework and quantitative analysis models, providing systematic support for investment decisions. He regularly publishes market insight reports that are widely cited by authoritative media including the Financial Times and Wall Street Journal.
Partner & COO
Former Global Partner at Boston Consulting Group (BCG), PhD in Engineering from MIT. Over 15 years of management consulting and corporate operations experience, focusing on enterprise digital transformation and operational efficiency improvement.
Mr. Chen is responsible for HanLing Capital's post-investment management system, providing systematic value creation solutions for portfolio companies. His "Operational Excellence Accelerator" methodology has been successfully implemented in multiple portfolio companies, improving operational efficiency by an average of over 20%.
Partner & Legal and Compliance Officer
JD from Yale University, former partner at a top U.S. law firm, focusing on cross-border M&A, private equity, and regulatory compliance matters. Qualified to practice law in both China and the United States.
Mr. Zhao is responsible for building HanLing Capital's legal risk control system, ensuring investment processes are compliant and efficient. He has rich experience in complex transaction structure design and cross-border investment regulation, having participated in multiple industry benchmark M&A restructuring projects.
Partner & ESG Investment Officer
PhD in Environmental Policy from Oxford University, former Senior Advisor at the United Nations Development Programme, and ESG Investment Officer at an internationally renowned asset management company.
Ms. Lin leads HanLing Capital's sustainable investment strategy, systematically integrating ESG factors into the investment process. Her established ESG assessment framework is widely recognized in the industry, having won the title of "Asian Responsible Investment Pioneer". She regularly publishes sustainable finance research articles, promoting industry best practices.
Headquarters: 30/F, Tower 3, China World Trade Center, 1 Jianguomenwai Avenue, Chaoyang District, Beijing
Shanghai Office: 25/F, Huiya Tower, 1233 Lujiazui Ring Road, Pudong New District, Shanghai
Hong Kong Office: 35/F, International Finance Centre II, 8 Finance Street, Central, Hong Kong
Tel: +86 10 8888 9999
Email: info@hanlingcapital.com
Media Contact: media@hanlingcapital.com
Recruitment: careers@hanlingcapital.com
Investor Relations: ir@hanlingcapital.com